References
- Bloor K, Freemantle N. Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors. BMJ 1996; 312: 1525–7
- Comptroller and Auditor General. Prescribing practices and the development of general practitioner services. The Stationery Office, Dublin 1997
- Walley T, Murphy M, Codd M, Johnston Z, Quirke T. Effects of a Monetary Incentive on Primary Care Prescribing in Ireland: Changes in Prescribing Patterns In One Health Board 1990–1995. Pharmacoepidemiology and Drug Safety 2000; 9: 591–8
- Uiffe S, Munro J. General practitioners and incentives. BMJ 1993; 307: 1156–7
- Grumbach K, Osmond D, Vranizan K, Jaffe D, Bindman AB. Primary care physicians' experience of financial incentives in managed-care systems. N Engl J Med 1998; 339: 1516–21
- Miller T E, Sage WM. Disclosing physician financial incentives. JAMA 1999; 281: 1424–30
- Bradley C P, Taylor R J, Blenkinsopp A. Primary care - opportunities and threats. Developing prescribing in primary care. BMJ 1997; 314: 744–7
- Keeble B, Keeble A. Satisfaction with the NHS: what is it and can we measure it?. J R Coll Gen Tract 1989; 39: 269–70
- Fakhoury WK. The UK Annual Patient Satisfaction Survey: can it really reflect the quality of the NHS?. Public Health Med 1998; 20: 484–5
- Wilson R, Buchan I, Walley T. Alterations in prescribing by GP Fundholders; an observational study. BMJ 1995; 311: 1347–50
- Bateman D N, Campbell M, Donaldson L J, Roberts S J, Smith JM. A prescribing incentive scheme for non-fundholding general practices: an observational study. BMJ 1996; 313: 535–8
- Wilson R, Hatcher J, Barton S, Walley T. Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non fundholders. Br J Gen Bract 1999; 49: 431–5
- Avery A, Wetzels R, Rodgers S. Do general practitioners working in practices with high or low prescribing costs have different views on prescribing cost issues. Br J Gen Pract 2000; 50: 100–4
- Durand-Zaleski I, Colin C, Blum-Boisgard C. An attempt to save money by using mandatory practice guidelines in France. BMJ 1997; 315: 943–6
- Durieux P, Chaix-Couturicr C, Durand-Zaleski I, Ravaud P. From clinical recommendations to mandatory practice. The introduction of regulatory practice guidelines in the French healthcare system. Int J Technol Assess Health Care 2000; 16: 969–75
- Schoffski O. Consequences of implementing a drug budget for office-based physicians in Germany. Pharmacoeconomics 1996; 10: 37–47, Suppl 2
- Dowell J, Snadden S, Dunbar J. Changing to generic formulary: how one fundholding practice reduced prescribing costs. BMJ 1995; 310: 505–8
- Wilson R, Hatcher J, Barton S, Walley T. General practice fundholders prescribing savings in one region of the UK 1991–4. Health Policy 1997; 42: 29–37
- Delnoij D, Brenner G. Importing budget systems from other countries: what can we learn from the German drug budget and the British GP fundholding?. Health Policy 2001; 52: 157–69
- Chaix-Couturier C, Durand-Zaleski I, Jolly D, Durieux P. Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues. Int J Quality Health Care 2000; 12: 133–42
- Gosden T, Forand F, Kristiansen I, et al. Capitation, salary, fee per service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane Database Syst Rev 2000; 4
- Russell D, Luthra M, Plastow E, Airdrie R, Marshall M. Cost effective prescribing in general practice: patients' attitudes to financially motivated prescribing changes. Int J Pharm Practice 2000; 8: 27–32
- Neville R, Meekison D. The limited list: the patients' views. BMJ 1985; 291: 517
- Dowell J, Snadden D, Dunbar J. Rapid prescribing change: how do patients respond?. Soc Sci Med 1996; 43: 1543–9